Logo image of SPA.BR

SPADEL SA (SPA.BR) Stock Fundamental Analysis

Europe - EBR:SPA - BE0003798155 - Common Stock

228 EUR
0 (0%)
Last: 10/6/2025, 7:00:00 PM
Fundamental Rating

5

Overall SPA gets a fundamental rating of 5 out of 10. We evaluated SPA against 26 industry peers in the Beverages industry. SPA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. SPA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

SPA had positive earnings in the past year.
SPA had a positive operating cash flow in the past year.
Each year in the past 5 years SPA has been profitable.
Each year in the past 5 years SPA had a positive operating cash flow.
SPA.BR Yearly Net Income VS EBIT VS OCF VS FCFSPA.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

SPA's Return On Assets of 8.70% is amongst the best of the industry. SPA outperforms 88.46% of its industry peers.
Looking at the Return On Equity, with a value of 13.47%, SPA is in the better half of the industry, outperforming 73.08% of the companies in the same industry.
SPA's Return On Invested Capital of 11.79% is fine compared to the rest of the industry. SPA outperforms 76.92% of its industry peers.
SPA had an Average Return On Invested Capital over the past 3 years of 8.57%. This is in line with the industry average of 8.66%.
The 3 year average ROIC (8.57%) for SPA is below the current ROIC(11.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.7%
ROE 13.47%
ROIC 11.79%
ROA(3y)6.19%
ROA(5y)6.45%
ROE(3y)9.43%
ROE(5y)10.16%
ROIC(3y)8.57%
ROIC(5y)9.02%
SPA.BR Yearly ROA, ROE, ROICSPA.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 10.90%, SPA is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
In the last couple of years the Profit Margin of SPA has grown nicely.
SPA has a worse Operating Margin (13.14%) than 61.54% of its industry peers.
SPA's Operating Margin has improved in the last couple of years.
SPA has a worse Gross Margin (39.57%) than 69.23% of its industry peers.
SPA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.14%
PM (TTM) 10.9%
GM 39.57%
OM growth 3Y-0.5%
OM growth 5Y1.58%
PM growth 3Y4.62%
PM growth 5Y3.65%
GM growth 3Y1.4%
GM growth 5Y1.36%
SPA.BR Yearly Profit, Operating, Gross MarginsSPA.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SPA is still creating some value.
SPA has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, SPA has about the same amount of shares outstanding.
The debt/assets ratio for SPA is higher compared to a year ago.
SPA.BR Yearly Shares OutstandingSPA.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
SPA.BR Yearly Total Debt VS Total AssetsSPA.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

SPA has an Altman-Z score of 5.53. This indicates that SPA is financially healthy and has little risk of bankruptcy at the moment.
SPA has a better Altman-Z score (5.53) than 96.15% of its industry peers.
The Debt to FCF ratio of SPA is 0.13, which is an excellent value as it means it would take SPA, only 0.13 years of fcf income to pay off all of its debts.
SPA has a Debt to FCF ratio of 0.13. This is amongst the best in the industry. SPA outperforms 96.15% of its industry peers.
SPA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
SPA has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. SPA outperforms 96.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Altman-Z 5.53
ROIC/WACC1.49
WACC7.89%
SPA.BR Yearly LT Debt VS Equity VS FCFSPA.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.88 indicates that SPA should not have too much problems paying its short term obligations.
SPA has a better Current ratio (1.88) than 69.23% of its industry peers.
SPA has a Quick Ratio of 1.70. This is a normal value and indicates that SPA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.70, SPA belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.7
SPA.BR Yearly Current Assets VS Current LiabilitesSPA.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

SPA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.61%, which is quite impressive.
SPA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.75% yearly.
SPA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.40%.
The Revenue has been growing slightly by 4.92% on average over the past years.
EPS 1Y (TTM)26.61%
EPS 3Y15.47%
EPS 5Y8.75%
EPS Q2Q%10.68%
Revenue 1Y (TTM)11.4%
Revenue growth 3Y10.37%
Revenue growth 5Y4.92%
Sales Q2Q%10.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SPA.BR Yearly Revenue VS EstimatesSPA.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.69 indicates a rather expensive valuation of SPA.
Compared to the rest of the industry, the Price/Earnings ratio of SPA is on the same level as its industry peers.
SPA is valuated rather cheaply when we compare the Price/Earnings ratio to 27.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.69
Fwd PE N/A
SPA.BR Price Earnings VS Forward Price EarningsSPA.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

SPA's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as SPA.
Industry RankSector Rank
P/FCF 23.83
EV/EBITDA 10.74
SPA.BR Per share dataSPA.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The decent profitability rating of SPA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.48
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

SPA has a yearly dividend return of 0.98%, which is pretty low.
With a Dividend Yield of 0.98, SPA pays less dividend than the industry average, which is at 3.01. 84.62% of the companies listed in the same industry pay a better dividend than SPA!
Compared to an average S&P500 Dividend Yield of 2.44, SPA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.98%

5.2 History

The dividend of SPA has a limited annual growth rate of 1.92%.
Dividend Growth(5Y)1.92%
Div Incr Years2
Div Non Decr Years2
SPA.BR Yearly Dividends per shareSPA.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

30.45% of the earnings are spent on dividend by SPA. This is a low number and sustainable payout ratio.
The dividend of SPA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP30.45%
EPS Next 2YN/A
EPS Next 3YN/A
SPA.BR Yearly Income VS Free CF VS DividendSPA.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SPA.BR Dividend Payout.SPA.BR Dividend Payout, showing the Payout Ratio.SPA.BR Dividend Payout.PayoutRetained Earnings

More info and screens

SPADEL SA

EBR:SPA (10/6/2025, 7:00:00 PM)

228

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)09-01 2025-09-01
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners97.59%
Ins Owner ChangeN/A
Market Cap946.20M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.98%
Yearly Dividend2.2
Dividend Growth(5Y)1.92%
DP30.45%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.69
Fwd PE N/A
P/S 2.37
P/FCF 23.83
P/OCF 13.8
P/B 2.92
P/tB 4.43
EV/EBITDA 10.74
EPS(TTM)10.51
EY4.61%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)9.57
FCFY4.2%
OCF(TTM)16.53
OCFY7.25%
SpS96.38
BVpS78.04
TBVpS51.43
PEG (NY)N/A
PEG (5Y)2.48
Profitability
Industry RankSector Rank
ROA 8.7%
ROE 13.47%
ROCE 14.63%
ROIC 11.79%
ROICexc 19.37%
ROICexgc 39.13%
OM 13.14%
PM (TTM) 10.9%
GM 39.57%
FCFM 9.93%
ROA(3y)6.19%
ROA(5y)6.45%
ROE(3y)9.43%
ROE(5y)10.16%
ROIC(3y)8.57%
ROIC(5y)9.02%
ROICexc(3y)13.94%
ROICexc(5y)13.81%
ROICexgc(3y)32.94%
ROICexgc(5y)32.52%
ROCE(3y)10.63%
ROCE(5y)11.39%
ROICexcg growth 3Y14.92%
ROICexcg growth 5Y8.53%
ROICexc growth 3Y13.66%
ROICexc growth 5Y8.37%
OM growth 3Y-0.5%
OM growth 5Y1.58%
PM growth 3Y4.62%
PM growth 5Y3.65%
GM growth 3Y1.4%
GM growth 5Y1.36%
F-Score8
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Debt/EBITDA 0.04
Cap/Depr 125.99%
Cap/Sales 7.22%
Interest Coverage 73.39
Cash Conversion 90.89%
Profit Quality 91.05%
Current Ratio 1.88
Quick Ratio 1.7
Altman-Z 5.53
F-Score8
WACC7.89%
ROIC/WACC1.49
Cap/Depr(3y)93.53%
Cap/Depr(5y)93.22%
Cap/Sales(3y)5.83%
Cap/Sales(5y)6.29%
Profit Quality(3y)136.29%
Profit Quality(5y)124.06%
High Growth Momentum
Growth
EPS 1Y (TTM)26.61%
EPS 3Y15.47%
EPS 5Y8.75%
EPS Q2Q%10.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.4%
Revenue growth 3Y10.37%
Revenue growth 5Y4.92%
Sales Q2Q%10.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.43%
EBIT growth 3Y9.82%
EBIT growth 5Y6.57%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.09%
FCF growth 3Y16.51%
FCF growth 5Y18.57%
OCF growth 1Y85.3%
OCF growth 3Y13.89%
OCF growth 5Y11.4%